Objective
Chlamydia trachomatis (CT) infections are responsible for both the world leading cause of blindness (trachoma) and the most prevalent sexually transmitted disease which is strongly associated with pelvic inflammatory disease, ectopic pregnancy, and tubal infertility. Preliminary twin study-based findings of members of this consortium estimate that there is a 40% genetic predisposition to CT infections. In order to fully exploit human genomics in the battle against CT infections, it is necessary to reliably determine aforementioned genetic predisposition at the gene level to CT infection and to define a genetic fingerprint that can be used as a marker for this predisposition. The EpiGenChlamydia CA aims to structure trans-national research to such degree that comparative genomics and genetic epidemiology on large numbers of unrelated individuals can be performed.
Fields of science
Topic(s)
Call for proposal
FP6-2005-LIFESCIHEALTH-6
See other projects for this call
Funding Scheme
CA - Coordination actionCoordinator
Amsterdam
Netherlands
Participants (18)
Amsterdam
Duarte, California
Rotterdam
London
Helsinki
London
Houten
Atlanta
Amsterdam
Banjul
Bilthoven
Helsinki
Amsterdam
Trondheim
Oxford
Maastricht
Uppsala